https://ir.bioaffinitytech.com/news-events/press-releases/rss en-us https://s3.amazonaws.com/equisolve-dev4/bioaffinitytech/files/theme/images/logo-sm.png Equisolve Investor Relations Suite https://ir.bioaffinitytech.com/news-events/press-releases/detail/198/bioaffinity-technologies-regains-compliance-with-nasdaq-listing-requirements Wed, 09 Sep 26 08:00:00 -0400 https://ir.bioaffinitytech.com/news-events/press-releases/detail/198/bioaffinity-technologies-regains-compliance-with-nasdaq-listing-requirements https://ir.bioaffinitytech.com/news-events/press-releases/detail/197/bioaffinity-technologies-to-participate-in-the-h-c-wainwright-28th-annual-global-investment-conference Thu, 03 Sep 26 16:30:00 -0400 https://ir.bioaffinitytech.com/news-events/press-releases/detail/197/bioaffinity-technologies-to-participate-in-the-h-c-wainwright-28th-annual-global-investment-conference https://ir.bioaffinitytech.com/news-events/press-releases/detail/196/bioaffinity-technologies-advances-cypath-lung-for-surveillance-of-lung-cancer-survivors Tue, 01 Sep 26 08:00:00 -0400 https://ir.bioaffinitytech.com/news-events/press-releases/detail/196/bioaffinity-technologies-advances-cypath-lung-for-surveillance-of-lung-cancer-survivors https://ir.bioaffinitytech.com/news-events/press-releases/detail/195/bioaffinity-technologies-announces-1-for-15-reverse-stock-split-effective-at-the-open-of-trading-on-august-24-2026 Thu, 20 Aug 26 08:00:00 -0400 https://ir.bioaffinitytech.com/news-events/press-releases/detail/195/bioaffinity-technologies-announces-1-for-15-reverse-stock-split-effective-at-the-open-of-trading-on-august-24-2026 https://ir.bioaffinitytech.com/news-events/press-releases/detail/194/bioaffinity-technologies-and-avmedical-announce-nationwide-federal-healthcare-distribution-agreement-for-cypath-lung Tue, 18 Aug 26 08:00:00 -0400 https://ir.bioaffinitytech.com/news-events/press-releases/detail/194/bioaffinity-technologies-and-avmedical-announce-nationwide-federal-healthcare-distribution-agreement-for-cypath-lung https://ir.bioaffinitytech.com/news-events/press-releases/detail/193/bioaffinity-technologies-announces-closing-of-4m-private-placement-offering-priced-at-the-market-under-nasdaq-rules Fri, 14 Aug 26 11:07:00 -0400 https://ir.bioaffinitytech.com/news-events/press-releases/detail/193/bioaffinity-technologies-announces-closing-of-4m-private-placement-offering-priced-at-the-market-under-nasdaq-rules https://ir.bioaffinitytech.com/news-events/press-releases/detail/192/bioaffinity-technologies-announces-pricing-of-4m-private-placement-offering-priced-at-the-market-under-nasdaq-rules Thu, 13 Aug 26 09:07:00 -0400 https://ir.bioaffinitytech.com/news-events/press-releases/detail/192/bioaffinity-technologies-announces-pricing-of-4m-private-placement-offering-priced-at-the-market-under-nasdaq-rules https://ir.bioaffinitytech.com/news-events/press-releases/detail/191/bioaffinity-technologies-reports-second-quarter-2026-results-and-continued-strong-commercial-momentum-for-cypath-lung Fri, 07 Aug 26 08:00:00 -0400 https://ir.bioaffinitytech.com/news-events/press-releases/detail/191/bioaffinity-technologies-reports-second-quarter-2026-results-and-continued-strong-commercial-momentum-for-cypath-lung https://ir.bioaffinitytech.com/news-events/press-releases/detail/190/bioaffinity-technologies-publishes-new-clinical-framework-addressing-growing-market-for-pulmonary-nodule-risk-stratification-and-early-lung-cancer-detection-using-cypath-lung Mon, 27 Jul 26 08:08:00 -0400 https://ir.bioaffinitytech.com/news-events/press-releases/detail/190/bioaffinity-technologies-publishes-new-clinical-framework-addressing-growing-market-for-pulmonary-nodule-risk-stratification-and-early-lung-cancer-detection-using-cypath-lung https://ir.bioaffinitytech.com/news-events/press-releases/detail/189/bioaffinity-technologies-and-pictor-inc-partner-to-develop-and-commercialize-bioaffinitys-diagnostics-for-asthma-and-copd Wed, 22 Jul 26 08:08:00 -0400 https://ir.bioaffinitytech.com/news-events/press-releases/detail/189/bioaffinity-technologies-and-pictor-inc-partner-to-develop-and-commercialize-bioaffinitys-diagnostics-for-asthma-and-copd